What Cells Are The Primary Targets For Hiv

Here's a taste of what TheBody.com has to offer on this topic:
Get the Facts
Test Positive Aware Network

The Feminization of an Epidemic

...Conference of Retroviruses and Opportunistic Infections (CROI) in Montreal, Canada a few months ago. PRO2000 (0.5%) is a highly negatively-charged molecule (a polyanionic polymer) that is designed to interfere with HIV entry into target calls. The HPTN035 trial was also designed to study another microbicide product (BufferGel) whose primary action is to lower vaginal pH levels. The trial enrolled 3,909 women from Malawi, South Africa, the...
Ask the Experts

HIV and vitamins

Hi i contracted hiv about a year ago...and im currently on atripla...my viral load is low...basically i wanna know is it okay to take antioxicants with the meds, to better improve my health and is it okay to take a safe compound to help me build...
Nelson Vergel, B.S.Ch.E., M.B.A.

Response from Nelson Vergel, B.S.Ch.E., M.B.A.

Program for Wellness Restoration
...Your question is probably the most popular in my column. Here are the main answers I have given for immune boosting supplements, protein supplements and creatine. Let me know if this satisfies your need, Read more »

Psycological response to longterm HIV diagnosis?

I read a most interesting and self confirming article in the May/June Issue of PA (Positively Aware) magazine. It was titled, "Is it all in your head?" Since I have been diagnosed now being over 16 years, I have been finding myself depressed, mood...
Robert J. Frascino, M.D.

Response from Robert J. Frascino, M.D.

The Robert James Frascino AIDS Foundation
...uses one of two coreceptors, CCR5 or CXCR4, along with the CD4 cell surface receptor to enter cells. In the brain, the primarytargets of HIV -- monocytes, macrophages, and microglia -- lack the CD4 receptor.Studies suggest that HIV variants that... Read more »

Pontential new target for HIV MEDS with A3G

Hi Dr Keith, thank you for your time and work you put into helping people with hiv,What can you let us know about A3G and maybe changing the way we compat hiv..thank you once again Anton Scientists continue to unravel a potential new target for HIV...
Keith Henry, M.D.

Response from Keith Henry, M.D.

University of Minnesota, School of Medicine
...This is a promising new target for anti-HIV drug development but there is no A3G-related candidate drug currently under clinical (human) study that would likely Read more »

Employer targeting me for HIV

My employer switched benefit plans 3 years ago and became self insured. After the first year, the personnel director advised that they were hiring a third party benefit administrator "because she knows way more than she should know about us". ...
Lynn L. Franzoi

Response from Lynn L. Franzoi

Worldwide Benefits for Fox, Inc.
The best thing to do would be to contact an attorney to discuss the situation and seek advice. Read more »
Urban Coalition for HIV/AIDS Prevention Services

In Response to Reported Case of Multi-Drug Resistant HIV in NYC, HIV Prevention Leaders Urged a Clear and Targeted Public Health Response, Increased Resources for Primary HIV Prevention and Continued Collaboration With Medical Providers

...cases of AIDS. UCHAPS called upon state and local governments, health agencies and prevention programs to conduct a clear and targeted public health response, including increased resources for primary prevention, increased public awareness, and... Read more »
Treatment Action Group

Dendritic Cells in Drag: Inauspicious Debut for HIV Specific CTLs; New Concerns about IL-12; Neutralizing Approaches for "Bad" Cytokines; Parke-Davis Targets Cellular Factors

...cytokine as an experimental KS treatment. Steve Miles of UCLA is currently following up this surprising finding. Novel Drug Targets Cellular Factor A researcher from the CDC presented preclinical data on two related compounds donated by... Read more »
Gay Men's Health Crisis

News From the Bench

...persons. Gilead says their prodrug technology allows a drug to specifically target the white blood cells that are the primarytargets of HIV. The technology has already been clinically tested in studies of a prodrug of Tenofovir, called GS 7340.... Read more »
U.S. National Institute of Allergy and Infectious Diseases

Questions and Answers: A Large International HIV/AIDS Study Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)

...cells per cubic millimeter (mm 3 ) of blood. (CD4+ cells are a type of infection-fighting white blood cell and are a primarytarget of HIV.) Volunteers were randomized to receive one of two antiretroviral treatment (ART) strategies: continuous... Read more »